An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma

Ishikawa, T; Hasegawa, I; Hirosawa, H; Honmou, T; Sakai, N; Igarashi, T; Yamazaki, S; Kobayashi, T; Sato, T; Iwanaga, A; Sano, T; Yokoyama, J; Honma, T

Ishikawa, T (通讯作者),Saiseikai Niigata Hosp, Dept Gastroenterol, Teraji 280-7, Niigata 9501104, Japan.

IN VIVO, 2023; 37 (2): 836

Abstract

Background/Aim: Lenvatinib is available as a molecular target agent for hepatocellular carcinoma (HCC). In this study, we investigated the popping phe......

Full Text Link